Oral treatment with amitriptyline induces coenzyme Q deficiency and oxidative stress in psychiatric patients

Journal of Psychiatric Research

Volumn 46, Issue 3, 2012, Pages 341-345

  Moreno Fernández, Ana M ^a   Cordero, Mario D ^a,b,c   Garrido Maraver, Juan ^b,c   Alcocer Gómez, Elísabet ^d   Casas Barquero, Nieves ^e   Carmona López, María I ^a   Sánchez Alcázar, José Antonio ^b,c   de Miguel, Manuel ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

^b UNIVERSIDAD PABLO DE OLAVIDE   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d UNIVERSITY OF SEVILLE   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

Amitriptyline; Coenzyme Q; Lipid peroxidation; Oxidative stress

Indexed keywords

AMITRIPTYLINE; CITRATE SYNTHASE; UBIDECARENONE;

ADULT; ARTICLE; CLINICAL ARTICLE; COENZYME Q DEFICIENCY; CONTROLLED STUDY; DEPRESSION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; ENZYME DEFICIENCY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID PEROXIDATION; MALE; MITOCHONDRIAL TOXICITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 84857139327     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2011.11.002     Document Type: Article

References (29)

1. Bartholomä P., Erlandsson N., Kaufmannn K., Rossler O.G., Baumann B., Wirth T., et al. Neuronal cell death induced by antidepressants: lack of correlation with Egr-1, NF-KB and extracellular signal-regulated protein kinase activation. Biochemical Pharmacology 2002, 63:1507-1516.
2. Battino M., Fato R., Parenti-Castelli G., Lenaz G. Coenzyme Q can control the efficiency of oxidative phosphorylation. International Journal of Tissue Reactions 1990, 12:137-144.
3. Bautista-Ferrufino M.R., Cordero M.D., Sánchez-Alcázar J.A., Illanes M., Fernández-Rodríguez A., Navas P., et al. Amitriptyline induces coenzyme Q deficiency and oxidative damage in mouse lung and liver. Toxicology Letters 2011, 204:32-37.
4. Bentinger M., Brismar K., Dallner G. The antioxidant role of coenzyme Q. Mitochondrion 2007, 7:S41-S50.
5. Ben-Shachar D., Karry R. Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression. PLoS One 2008, 3:e3676.
6. Cordero M.D., Moreno-Fernández A.M., Gomez-Skarmeta J.L., De Miguel M., Garrido-Maraver J., Oropesa-ávila M., Rodríguez-Hernández A., et al. Coenzyme Q10 and alpha-tocopherol protect against amitriptyline toxicity. Toxicology and Applied Pharmacology 2009, 235:329-337.
7. Cordero M.D., Sánchez-Alcázar J.A., Bautista-Ferrufino M.R., Carmona-López M.I., Illanes M., Ríos M.J., et al. Acute oxidant damage promoted on cancer cells by amitriptyline in comparison with some common chemotherapeutic drugs. Anticancer Drugs 2010, 21:932-944.
8. De Cabo R., Cabello R., Ríos M., López-Lluch G., Ingram D.K., Lane M.A., et al. Calorie restriction attenuates age-related alterations in the plasma membrane antioxidant system in rat liver. Experimental Gerontology 2004, 39:297-304.
9. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biology & Medicine 1991, 11:81-128.
10. Garrabou G., Soriano A., Lopez S., Guallar J.P., Giralt M., Villarroya F., et al. Reversible inhibition of mitochondrial protein synthesis during linezolid-related hyperlactatemia. Antimicrobial Agents and Chemotherapy 2007, 51:962-967.
11. Gruber A.J., Hudson J.I., Pope H.G. The management of treatment-resistant depression in disorders on the interface of psychiatry and medicine. Fibromyalgia, chronic fatigue syndrome, migraine, irritable bowel syndrome, atypical facial pain, and premenstrual dysphoric disorder. The Psychiatric Clinics of North America 1996, 19:351-359.
12. Haas R.H., Parikh S., Falk M.J., Saneto R.P., Wolf N.I., Darin N., et al. The in-depth evaluation of suspected mitochondrial disease. Molecular Genetics and Metabolism 2008, 94:16-37.
13. Hroudova J., Fisar Z. Activities of respiratory chain complexes and citrate synthase influenced by pharmacologically different antidepressants and mood stabilizers. Neuro Endocrinology Letters 2010, 31:336-342.
14. Indo H.P., Davidson M., Yen H.C., Suenaga S., Tomita K., Nishii T., et al. Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage. Mitochondrion 2007, 7:106-118.
15. Land J.M., Heales S.J., Duncan A.J., Hargreaves I.P. Some observations upon biochemical causes of ataxia and a new disease entity ubiquinone, CoQ10 deficiency. Neurochemical Research 2007, 32:837-843.
16. Lenaz G., Samorì B., Fato R., Battino M., Parenti Castelli G., Domini I. Localization and preferred orientations of ubiquinone homologs in model bilayers. Biochemistry and Cell Biology 1992, 70:504-514.
17. Lenaz G., Fato R., Formiggini G., Genova M.L. The role of Coenzyme Q in mitochondrial electron transport. Mitochondrion 2007, 7:S8-33.
18. Maes M., Mihaylova I., Kubera M., Uytterhoeven M., Vrydags N., Bosmans E. Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness. Neuro Endocrinology Letters 2009, 30:462-469.
19. Maes M. An intriguing and hitherto unexplained co-occurrence: Depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35(3):784-794.
20. Murphy M.P. How mitochondria produce reactive oxygen species. Biochemical Journal 2009, 417:1-13.
21. Perica M.M., Delas I. Essential fatty acids and psychiatric disorders. Nutrition in Clinical Practice 2011, 26:409-425.
22. Post A., Crochemore C., Uhr M., Holsboer F., Behl C. Differential induction of NF-KB activity and neural cell death by antidepressants in vitro. European Journal of Neuroscience 2000, 12:4331-4337.
23. Rauchová H., Battino M., Fato R., Lenaz G., Drahota Z. Coenzyme Q-pool function in glycerol-3-phosphate oxidation in hamster brown adipose tissue mitochondria. Journal of Bioenergy and Biomembranes 1992, 24:235-241.
24. Rezin G.T., Cardoso M.R., Gonçalves C.L., Scaini G., Fraga D.B., Riegel R.E., et al. Inhibition of mitochondrial respiratory chain in brain of rats subjected to an experimental model of depression. Neurochemistry International 2008, 53:395-400.
25. Scaglia F. The role of mitochondrial dysfunction in psychiatric disease. Developmental Disabilities Research Reviews 2010, 16:136-143.
26. Slamon N.D., Pentreath V.W. Antioxidant defense against antidepressants in C6 and 1321N1 cells. Chemico-Biological Interactions 2000, 127:181-199.
27. Trounce I.A., Kim Y.L., Jun A.S., Wallace D.C. Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods in Enzymology 1996, 264:484-509.
28. Turunen M., Olsson J., Dallner G. Metabolism and function of coenzyme Q. Biochimica et Biophysica Acta 2004, 1660:171-179.
29. Viola G., Miolo G., Vedaldi D., Dall'Acqua F. In vitro studies of the phototoxic potential of the antidepressant drugs amitriptyline and imipramine. Il Farmaco 2000, 55:211-218.